Induction of remission in female rheumatoid arthritis patients is associated with stabilization of myocardial abnormalities: a prospective cardiac magnetic resonance follow-up study

References

• Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008;5:35–61.
   Google Scholar
• Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008;59:1690–7.
   PubMed Web of Science ®Google Scholar
• Pedersen JK, Holst R, Primdahl J, Svendsen AJ, Hørslev-Petersen K. Mortality and its predictors in patients with rheumatoid arthritis: a Danish population-based inception cohort study. Scand J Rheumatol 2018;47:371–7.
   PubMed Web of Science ®Google Scholar
• Logstrup BB, Ellingsen T, Pedersen AB, Kjaersgaard A, Botker HE, Maeng M. Development of heart failure in patients with rheumatoid arthritis: a Danish population-based study. Eur J Clin Invest 2018;48:e12915.
   PubMed Web of Science ®Google Scholar
• Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Torp-Pedersen C, et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 2011;70:929–34.
   PubMed Web of Science ®Google Scholar
• Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402–11.
   PubMed Web of Science ®Google Scholar
• Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005;52:412–20.
   PubMed Web of Science ®Google Scholar
• Crowson CS, Rollefstad S, Ikdahl E, Kitas GD, PLCM VR, Gabriel SE, et al. Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 2018;77:48–54.
   PubMed Web of Science ®Google Scholar
• Logstrup BB, Deibjerg LK, Hedemann-Andersen A, Ellingsen T. Left ventricular function in treatment-naive early rheumatoid arthritis. Am J Cardiovasc Dis 2014;4:79–86.
   PubMedGoogle Scholar
• Giles JT, Fernandes V, Lima JA, Bathon JM. Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 2005;7:195–207.
   PubMed Web of Science ®Google Scholar
• Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging 2015;8:526–36.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kobayashi Y, Yokoe I, Akashi Y, Takei M, Giles JT. Magnetic resonance imaging-detected myocardial inflammation and fibrosis in rheumatoid arthritis: associations with disease characteristics and N-terminal pro-brain natriuretic peptide levels. Arthritis Care Res (Hoboken) 2017;69:1304–11.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kobayashi H, Giles J, Yokoe I, Nishiwaki A, Takei M. Impact of biological treatment on left ventricular function and morphology in rheumatoid arthritis patients without cardiac symptoms, assessed by cardiac magnetic resonance imaging. Scand J Rheumatol 2017;46:328–9.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kobayashi Y, Giles JT, Yoneyama K, Nakajima Y, Takei M. Tocilizumab treatment increases left ventricular ejection fraction and decreases left ventricular mass index in patients with rheumatoid arthritis without cardiac symptoms: assessed using 3.0 tesla cardiac magnetic resonance imaging. J Rheumatol 2014;41:1916–21.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kobayashi H, Giles JT, Hirano M, Nakajima Y, Takei M. Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Int J Rheum Dis 2016;19:1169–74.
   PubMed Web of Science ®Google Scholar
• Kotyla PJ, Owczarek A, Rakoczy J, Lewicki M, Kucharz EJ, Emery P. Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide. J Rheumatol 2012;39:701–6.
   PubMed Web of Science ®Google Scholar
• Mahrholdt H, Klem I, Sechtem U. Cardiovascular MRI for detection of myocardial viability and ischaemia. Heart 2007;93:122–9.
   PubMed Web of Science ®Google Scholar
• Schelbert EB, Messroghli DR. State of the art: clinical applications of cardiac T1 mapping. Radiology 2016;278:658–76.
   PubMed Web of Science ®Google Scholar
• Holmstrom M, Koivuniemi R, Korpi K, Kaasalainen T, Laine M, Kuuliala A, et al. Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis. Clin Exp Rheumatol 2016;34:416–23.
   PubMed Web of Science ®Google Scholar
• Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308–15.
   PubMed Web of Science ®Google Scholar
• Leirisalo-Repo M, Kautiainen H, Laasonen L, Korpela M, Kauppi MJ, Kaipiainen-Seppanen O, et al. Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo study). Ann Rheum Dis 2013;72:851–7.
   PubMed Web of Science ®Google Scholar
• van Gestel AM, Prevoo ML, van ‘T Hof MA, van Rijswijk MH. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34–40.
   PubMed Web of Science ®Google Scholar
• Fransen J, van Riel PL. The disease activity score and the EULAR response criteria. Rheum Dis Clin North Am 2009;35:745–57.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5.
   PubMed Web of Science ®Google Scholar
• Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539–42.
   PubMed Web of Science ®Google Scholar
• Smolen J, Landewé RB, Burmester J, Dougados M, Kerschbaumer A, McInnes I, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 2020;79:778–86.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Karabela G, Stavropoulos E, Gialafos E, Sfendouraki E, Kyrou L, et al. Imaging patterns of heart failure in rheumatoid arthritis evaluated by cardiovascular magnetic resonance. Int J Cardiol 2013;168:4333–5.
   PubMed Web of Science ®Google Scholar
• Koivuniemi R, Paimela L, Suomalainen R, Leirisalo-Repo M. Cardiovascular diseases in patients with rheumatoid arthritis. Scand J Rheumatol 2013;42:131–5.
   PubMed Web of Science ®Google Scholar
• Giles JT, Fert-Bober J, Park JK, Bingham CO, Andrade F, Fox-Talbot K, et al. Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study. Arthritis Res Ther 2012;14:R39.
   PubMed Web of Science ®Google Scholar
• Logstrup BB, Masic D, Laurbjerg TB, Blegvad J, Herly M, Kristensen LD, et al. Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study. Scand J Rheumatol 2017;46:432–40.
   PubMed Web of Science ®Google Scholar
• Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948–55.
   PubMed Web of Science ®Google Scholar
• Bradham W, Ormseth MJ, Elumogo C, Palanisamy S, Liu CY, Lawson MA, et al. Absence of fibrosis and inflammation by cardiac magnetic resonance imaging in rheumatoid arthritis patients with low to moderate disease activity. J Rheumatol 2018;45:1078–84.
   PubMed Web of Science ®Google Scholar